HER2-Peptide Vaccination of Patients With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Gastric Cancer|Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Sargramostim|DRUG: HER2-Peptid-Vakzine|DRUG: Imiquimod
Sponsor: Technical University of Munich